Form 4: Medicine Man Technologies Executive Granted Stock Options
SEC Form 4 Filing
Daniel Pabon, Chief Policy Officer of Medicine Man Technologies, Inc., was granted stock options to purchase 88,214 shares of Class A Common Stock on August 28, 2024.
Summary
- On August 28, 2024, Daniel Pabon, the Chief Policy Officer of Medicine Man Technologies, Inc. (SHWZ), was granted stock options.
- These options allow him to purchase 88,214 shares of Class A Common Stock at an exercise price of $1.03 per share.
- The options vest in four equal installments, starting on May 3, 2025.
- The options expire on August 28, 2034.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and generally viewed as a positive sign of aligning management interests with shareholders.
Positives
- The granting of stock options to a key executive aligns their interests with those of the shareholders.
- The vesting schedule encourages long-term commitment from the executive.
Future Outlook
The document does not contain any specific forward-looking statements regarding the company's future performance.
Industry Context
Stock option grants are a common practice in the cannabis industry to incentivize and retain key executives, especially in growth-oriented companies like Medicine Man Technologies.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages across various industries, including cannabis.
- The size of the grant and the vesting schedule are typical for executive-level positions in similarly sized companies.
- Comparing the exercise price and vesting schedule to those of competitors like Curaleaf, Trulieve, or Green Thumb Industries would provide a more detailed benchmark.
Stakeholder Impact
- Shareholders may view the stock option grant as a positive incentive for the Chief Policy Officer.
- Employees may see this as a sign of the company's commitment to its leadership team.
Key Dates
| Date | Description |
|---|---|
| 08/28/2024 | Date of transaction: Daniel Pabon was granted stock options. |
| 05/03/2025 | First vesting date for the stock options. |
| 08/28/2034 | Expiration date of the stock options. |
| 10/07/2024 | Date of Form 4 filing. |
Keywords
stock options, Medicine Man Technologies, SHWZ, Daniel Pabon, Chief Policy Officer, Form 4, beneficial ownership, equity securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.